Nrx pharmaceuticals to report first quarter 2022 results on may 16, 2022

--company to host conference call may 16, 2022, at 8:30am et-- radnor, pa. , may 10, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals"), a clinical-stage, biopharmaceutical company today announced that management will report first quarter 2022 financial results prior to the market open on may 16, 2022.
NRXP Ratings Summary
NRXP Quant Ranking